Trials / Completed
CompletedNCT07487142
Prevalence of Asymptomatic H Pylori Infection Among Patients Undergoing PCI and Impact of Its Eradication on Occurrence of GIT Symptoms and Bleeding"
"Prevalence of Asymptomatic Helicobacter Pylori Infection Among Patients Undergoing Percutaneous Coronary Intervention and Impact of Its Eradication on Occurrence of Gastrointestinal Symptoms and Bleeding"
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 121 (actual)
- Sponsor
- Beni-Suef University · Academic / Other
- Sex
- All
- Age
- 35 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
In the present study, the aim was to report the prevalence of positive H. pylori infection in an unselected population referred for coronary intervention and likely to required DAPT or DPI, also the study assessed impact of H. pylori eradication on occurrence of GI symptoms or bleeding during the follow up period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BISMUTH TETRACYCLINE METRONIDAZOLE OMEPRAZOLE | PCI patients h pylori positive |
Timeline
- Start date
- 2024-06-10
- Primary completion
- 2025-12-24
- Completion
- 2025-12-24
- First posted
- 2026-03-23
- Last updated
- 2026-03-23
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07487142. Inclusion in this directory is not an endorsement.